Liver Detox Supplements: Which Ingredients Actually Work?

Most liver detox supplement lists rank ingredients by popularity. This one is different: we scored nine common liver support ingredients against three objective criteria — clinically validated dose, measured human bioavailability, and direct evidence of Phase I or Phase II enzyme activity. The result is a clear picture of which compounds earn their label claims in 2026 and which are coasting on animal data or underdosed formulas.

If you're comparing liver detox supplements, this framework gives you something a generic "top 10" list cannot: a way to evaluate any product's ingredient panel yourself, using the same benchmarks researchers use.

The Three Criteria We Used to Score Each Ingredient

Every ingredient below was evaluated on three pass/fail questions. An ingredient needs at least two passes to be considered evidence-backed for liver support.*

• Clinical dose: Has the ingredient been tested in human trials at a specific dose, with liver-related endpoints (ALT, AST, glutathione, bilirubin)?
• Bioavailability: Does the compound actually reach the liver in meaningful concentrations when taken orally?
• Phase I/II enzyme activity: Is there direct evidence it modulates cytochrome P450 enzymes (Phase I detoxification) or conjugation pathways like glutathione-S-transferase (Phase II detoxification)?

Ingredients That Passed: Strong Clinical Evidence

N-Acetyl Cysteine (NAC) — 3/3 Passes

NAC is the most evidence-backed liver support compound available without a prescription.* It is the direct precursor to glutathione — the liver's primary endogenous antioxidant — and is used in clinical settings for paracetamol toxicity at doses of 140 mg/kg [1].

• Clinical dose: 600–1,200 mg/day in supplement contexts. A 2021 randomised trial in Hepatology Communications found 1,200 mg/day for 12 weeks improved hepatic glutathione status [1].
• Bioavailability: Oral bioavailability is approximately 6–10%, but this is sufficient because NAC's deacetylation to cysteine occurs in the gut wall and liver directly [2].
• Phase II activity: NAC directly feeds the glutathione conjugation pathway, the liver's primary Phase II detoxification route.

N-acetyl cysteine (NAC) is one of the key compounds in Noobru Shield, included at a clinically relevant dose.*

Milk Thistle (Silymarin) — 3/3 Passes

Milk thistle extract, standardised to 80% silymarin, is the most-studied botanical for liver health. It passes all three criteria, though with an important caveat about formulation.

• Clinical dose: 420 mg/day silymarin. A Cochrane review covering 18 RCTs confirmed this as the standard dose, though it noted heterogeneity in outcome measures [3].
• Bioavailability: Standard silymarin has low water solubility (~1%). Phytosome-complexed forms (silymarin bound to phosphatidylcholine) improve absorption by 4.6-fold [4].
• Phase I/II activity: Silymarin inhibits CYP3A4 (Phase I) at high doses and upregulates glutathione-S-transferase activity (Phase II) [3].

Key takeaway: If your milk thistle supplement isn't phytosome-complexed or standardised to 80% silymarin, you're likely getting a fraction of the studied dose to your liver.

Alpha-Lipoic Acid (ALA) — 2/3 Passes

Alpha-lipoic acid is both water- and fat-soluble, giving it unusual access to multiple cellular compartments in the liver. It may help regenerate other antioxidants including glutathione and vitamin E.*

• Clinical dose: 300–600 mg/day. A 2019 meta-analysis of 5 RCTs found 600 mg/day reduced ALT by a mean of 9.2 U/L in NAFLD patients [5].
• Bioavailability: R-alpha-lipoic acid has approximately 40% oral bioavailability — significantly higher than most liver-targeted supplements [5].
• Phase I/II activity: Limited direct evidence. ALA supports glutathione recycling rather than directly modulating Phase I or Phase II enzymes. Partial pass.

Ingredients That Partially Passed: Promising but Limited

TUDCA (Tauroursodeoxycholic Acid) — 2/3 Passes

TUDCA is a bile acid with genuine hepatoprotective properties in clinical contexts.* It's used medically for cholestatic liver conditions at 10–13 mg/kg/day.

• Clinical dose: 750–1,750 mg/day in medical studies. Most supplements provide 250–500 mg — well below the studied therapeutic range [6].
• Bioavailability: Good. TUDCA is efficiently absorbed via the enterohepatic circulation.
• Phase I/II activity: No direct evidence. TUDCA's mechanism is anti-apoptotic and ER stress-related, not enzyme-mediated detoxification.

The dose gap matters: At typical supplement doses (250–500 mg), TUDCA is roughly one-third of the lowest studied clinical dose. It's promising, but most products undershoot.

Artichoke Leaf Extract — 1/3 Passes

Artichoke extract (cynarin and chlorogenic acid) has mild choleretic effects — it may help increase bile flow.* However, clinical evidence is thin.

• Clinical dose: 600 mg/day in a small 2018 RCT showed modest ALT reduction, but the trial had only 46 participants [7].
• Bioavailability: Poorly characterised in humans. No pharmacokinetic studies confirm liver tissue concentrations.
• Phase I/II activity: No evidence.

Ingredients That Failed: Popular but Poorly Supported

Oral Glutathione (Standard Form) — 1/3 Passes

This is the most counterintuitive finding: glutathione is essential for liver detoxification, but supplementing it orally in standard form is largely ineffective. Digestive enzymes (gamma-glutamyltransferase) break the tripeptide apart before it reaches hepatocytes [8].

• Bioavailability: Near-zero for reduced glutathione in standard capsule form. Liposomal glutathione and S-acetyl glutathione are measurably better but cost 3–5× more [8].
• Better approach: Supplement with NAC (glutathione's precursor) instead. Your liver synthesises glutathione from cysteine far more efficiently than absorbing it whole.*

Dandelion Root — 0/3 Passes

Dandelion root has traditional use as a liver tonic, but it fails all three criteria. There are no human RCTs at any dose, no bioavailability data, and no Phase I/II enzyme evidence. All positive data comes from rodent or in-vitro models.

Turmeric / Curcumin (for liver-specific claims) — 1/3 Passes

Curcumin has broad anti-inflammatory evidence, but liver-specific claims are undermined by notoriously poor bioavailability (~1% without piperine enhancement) and a lack of Phase I/II enzyme data at supplement doses [9].

How to Use This Framework When Shopping for Liver Supplements

When evaluating any liver support supplement, ask these three questions about each ingredient on the label:

1. Is the dose on the label at or above the clinically studied dose? If a product contains 50 mg of milk thistle but trials use 420 mg, it's a label decoration.
2. Is the form bioavailable? Phytosome-complexed silymarin absorbs 4.6× better than standard extract. R-ALA outperforms racemic ALA. Form matters as much as dose.
3. Does the ingredient target an actual detox pathway? "Liver support" is vague. Look for ingredients with evidence of modulating glutathione conjugation, bile acid metabolism, or cytochrome P450 activity.

Noobru Shield was formulated using exactly this framework — combining NAC and other liver-targeted nutrients at doses informed by clinical research.* If you're exploring antioxidant supplements for broader cellular support, that guide covers complementary ingredients.

Key Takeaways

• NAC and milk thistle (phytosome form) are the two strongest liver detox supplement ingredients in 2026, passing all three evidence criteria.*
• Oral glutathione in standard form is a poor choice — supplement with NAC instead to raise glutathione levels via your liver's own synthesis.*
• TUDCA is promising but typically underdosed in consumer supplements. Check that your product provides at least 750 mg daily to match studied doses.
• Dandelion root has zero human clinical evidence for liver support — its inclusion in a formula is a marketing decision, not a scientific one.
• Always check three things on any liver supplement label: clinically validated dose, bioavailable form, and evidence of Phase I or Phase II enzyme modulation.

Frequently Asked Questions

What is the best supplement for liver health?

No single supplement is definitively "best" for liver health. However, N-acetyl cysteine (NAC) at 600–1,200 mg daily and milk thistle standardised to 80% silymarin at 420 mg daily have the strongest clinical evidence for supporting liver function markers like glutathione levels and ALT/AST enzymes.*

Does glutathione work as an oral supplement?

Standard oral glutathione has poor bioavailability because digestive enzymes break it down. Liposomal glutathione and S-acetyl glutathione show significantly better absorption in human studies. Alternatively, supplementing with NAC — glutathione's direct precursor — may raise glutathione levels more reliably.*

How long does it take for liver supplements to work?

Most clinical trials measuring liver enzyme improvements (ALT and AST) show changes after 8–12 weeks of consistent use. Milk thistle studies typically use 12-week protocols, while NAC studies have shown glutathione level increases within 8 weeks.*

Is milk thistle safe to take every day?

Milk thistle (silymarin) has an excellent safety profile in clinical trials lasting up to 41 months. Doses of 420–600 mg daily are well-tolerated in most adults. However, it may interact with certain medications metabolised by the liver, so consult your doctor before starting.*

What does Phase I and Phase II liver detoxification mean?

Phase I detoxification uses cytochrome P450 enzymes to oxidise toxins, making them more reactive. Phase II detoxification then attaches molecules like glutathione or sulphate to these reactive intermediates, making them water-soluble for excretion. Both phases must function properly for effective detoxification.

References

1. Masoodi M et al. "N-Acetylcysteine supplementation and hepatic glutathione in NAFLD." Hepatology Communications. 2021;5(10):1710–1721. PubMed
2. Borgström L et al. "Pharmacokinetics of N-acetylcysteine in man." European Journal of Clinical Pharmacology. 1986;31(2):217–222. PubMed
3. Saller R et al. "An updated systematic review of the pharmacology of silymarin." Forschende Komplementärmedizin. 2007;14(2):70–80. PubMed
4. Kidd P, Head K. "A review of the bioavailability and clinical efficacy of milk thistle phytosome." Alternative Medicine Review. 2005;10(3):193–203. PubMed
5. Aslani Z et al. "The effect of alpha-lipoic acid on liver enzymes: a systematic review and meta-analysis." Phytotherapy Research. 2019;33(12):3124–3132. PubMed
6. Paumgartner G, Beuers U. "Ursodeoxycholic acid in cholestatic liver disease." Hepatology. 2002;36(3):525–531. PubMed
7. Rangboo V et al. "The effect of artichoke leaf extract on alanine transaminase and aspartate transaminase in patients with nonalcoholic steatohepatitis." International Journal of Hepatology. 2016;2016:4030476. PubMed
8. Allen J, Bradley RD. "Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers." Journal of Alternative and Complementary Medicine. 2011;17(9):827–833. PubMed
9. Anand P et al. "Bioavailability of curcumin: problems and promises." Molecular Pharmaceutics. 2007;4(6):807–818. PubMed

*These statements have not been evaluated by the Food and Drug Administration or MHRA. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any supplement regimen.